United States · 
Who invested in Nina Biotherapeutics?
Nina Biotherapeutics's investors include Domain Associates.
2014
$1.0MVenture$2.5MVentureUnited States · Venture startup
Who invested in Nina Biotherapeutics
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Nina Biotherapeutics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$3.5Mraised across 2 rounds since 2013, from 2 sources
$1.0MVenture$2.5MVenture
- Latest round
- Venture, $2.5MDec 2013
- Step-upi
- 2.5×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $1.0M Mar 2013
- Biggest round
- $2.5M Venture · Dec 2013
- Between rounds
- 8 months from the last two
The rounds
- Dec 2013Venture$2.5M
No investor was named in the report.
Reported by sec.govSEC filing: $2.5M sold, first sale Nov 2013
- Mar 2013
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nina Biotherapeutics
How much has Nina Biotherapeutics raised?
Nina Biotherapeutics has raised $3.5M across 2 rounds since 2013.
When did Nina Biotherapeutics last raise?
Nina Biotherapeutics's most recent round was a Venture of $2.5M in Dec 2013.
What was Nina Biotherapeutics's biggest round?
Its most recent round, $2.5M in Dec 2013, is also its largest on record.
Who backed Nina Biotherapeutics first?
Nina Biotherapeutics's first round on record, in Mar 2013, was backed by Domain Associates.
What stage is Nina Biotherapeutics at?
Nina Biotherapeutics's latest named round is a Venture, in Dec 2013.
Where is Nina Biotherapeutics based?
Nina Biotherapeutics is based in the United States.
Companies like Nina Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.